NLRP3 and cryopyrin-associated periodic syndrome: Therefore, the effect of 4-OI on IL-1β release could (i) affect Il1b induction by reducing glycolysis, and (ii) block constitutively active NLRP3 p.D305N inflammasome associated with CAPS and thus impair IL-1β maturation.